{
    "ASSETS": {
        "Current Assets": {
            "Cash and cash equivalents": [
                12346,
                6911
            ],
            "Marketable debt securities": [
                3047,
                1848
            ],
            "Receivables": [
                7685,
                5747
            ],
            "Inventories": [
                4293,
                1195
            ],
            "Other current assets": [
                1983,
                2015
            ],
            "Total Current Assets": [
                29354,
                17716
            ]
        },
        "Property, plant and equipment": [
            6252,
            5027
        ],
        "Goodwill": [
            22488,
            6538
        ],
        "Other intangible assets": [
            63969,
            1091
        ],
        "Deferred income taxes": [
            510,
            815
        ],
        "Marketable debt securities": [
            767,
            1775
        ],
        "Other non-current assets": [
            6604,
            2024
        ],
        "Total Assets": [
            129944,
            34986
        ]
    },
    "LIABILITIES": {
        "Current Liabilities": {
            "Short-term debt obligations": [
                3346,
                1703
            ],
            "Accounts payable": [
                2445,
                1892
            ],
            "Other current liabilities": [
                12513,
                7059
            ],
            "Total Current Liabilities": [
                18304,
                10654
            ]
        },
        "Deferred income taxes": [
            6454,
            19
        ],
        "Long-term debt": [
            43387,
            5646
        ],
        "Other non-current liabilities": [
            10101,
            4540
        ],
        "Total Liabilities": [
            78246,
            20859
        ],
        "Commitments and contingencies": null
    },
    "EQUITY": {
        "Bristol-Myers Squibb Company Shareholders Equity": {
            "Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 3,568 in 2019 and 3,590 in 2018, liquidation value of $50 per share": null,
            "Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2019 and 2.2 billion issued in 2018": [
                292,
                221
            ],
            "Capital in excess of par value of stock": [
                43709,
                2081
            ],
            "Accumulated other comprehensive loss": [
                -1520,
                -2762
            ],
            "Retained earnings": [
                34474,
                34065
            ],
            "Less cost of treasury stock 672 million common shares in 2019 and 576 million common shares in 2018": [
                -25357,
                -19574
            ],
            "Total Bristol-Myers Squibb Company Shareholders' Equity": [
                51598,
                14031
            ]
        },
        "Noncontrolling interest": [
            100,
            96
        ],
        "Total Equity": [
            51698,
            14127
        ]
    },
    "Total Liabilities and Equity": [
        129944,
        34986
    ]
}